Cargando…
Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis
CONTEXTS: CD154 (commonly referred to as CD40-ligand) is a critical T cell factor that participates in the pathogenesis of autoimmune and is over-expressed in rheumatoid arthritis (RA). TNF-α blockade treatment had dramatic efficacy in RA. OBJECTIVE: To investigate whether TNF-α blockade treatment c...
Autores principales: | Tung, Chien-Hsueh, Lu, Ming-Chi, Lai, Ning-Sheng, Wu, Shu-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570341/ https://www.ncbi.nlm.nih.gov/pubmed/28837666 http://dx.doi.org/10.1371/journal.pone.0183726 |
Ejemplares similares
-
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis
por: Lai, Jenn-Haung, et al.
Publicado: (2019) -
A Role for CD154, the CD40 Ligand, in Granulomatous Inflammation
por: Villeneuve, Julien, et al.
Publicado: (2017) -
CD154: the atherosclerotic risk factor in rheumatoid arthritis?
por: Hassan, Ghada S, et al.
Publicado: (2013) -
Hydroxychloroquine inhibits CD154 expression in CD4(+) T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling
por: Wu, Shu-Fen, et al.
Publicado: (2017) -
RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis
por: Zheng, Xiufen, et al.
Publicado: (2010)